Lupin receives tentative U.S. FDA approval for Dolutegravir, Lamivudine and TLD tablets
TLD is recommended by WHO, USAID, and PEPFAR as a preferred first-line treatment regimen for the treatment of HIV in adults and pediatric patients weighing at least 35 kg